Biogen (BIIB) Amortization - Intangibles (2009 - 2026)

Biogen's Amortization - Intangibles history runs 18 years deep, the most recent figure standing at $168.2 million for Q2 2026.

• In Q2 2026, Amortization - Intangibles rose 28.5% year-over-year to $168.2 million; the TTM figure through Jun 2026 stood at $577.0 million (up 10.07% YoY), while the FY2025 annual figure was $515.0 million, up 15.29% from the prior year.
• Amortization - Intangibles for Q2 2026 stood at $168.2 million, up from $136.5 million in the prior quarter.
• The five-year high for Amortization - Intangibles was $175.0 million in Q4 2022, with the low at $50.2 million in Q1 2023.
• The 5-year median for Amortization - Intangibles is $99.4 million (2024), against an average of $104.0 million.
• Peak annual rise in Amortization - Intangibles reached 156.98% in 2022, while the deepest fall reached 88.83% in 2022.
• Biogen's Amortization - Intangibles stood at $175.0 million in 2022, then sank by 56.23% to $76.6 million in 2023, then surged by 97.39% to $151.2 million in 2024, then decreased by 9.66% to $136.6 million in 2025, then gained by 23.13% to $168.2 million in 2026.
• Business Quant data shows BIIB's Amortization - Intangibles at $168.2 million in Q2 2026, $136.5 million in Q1 2026, and $136.6 million in Q4 2025.